Brief: NanoCarrier says clinical trial of NC-6004

Nano Holdings

22/06/2016 03:55

June 22 (Reuters) - NanoCarrier Co Ltd  4571.T : 
     
    * Says it submitted CTA (Clinical Trial Authorization) of 
NC-6004 to regulatory authorities of EU regional 
     
    Source text in Japanese: https://goo.gl/pBWvbm 
    Further company Coverage:  4571.T  
 
 (Beijing Headline News) 
 ((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724; 
Reuters Messaging: qiujing.li.thomsonreuters.com@reuters.net))